Heart. Published Online First: 16 June 2009. doi:10.1136/hrt.2009.167221
Technology and guidelines |
Carotid disease: stenting versus endarterectomy
1 Leicester Royal Infirmary, United Kingdom
* To whom correspondence should be addressed. E-mail: ross.naylor{at}uhl-tr.nhs.uk.
Accepted 3 February 2009
Abstract
Introduced in the 1950s, carotid endarterectomy (CEA) proliferated in the 1970s only to become the subject of criticism in the 1980s when its appropriateness was questioned.1 Primacy was restored with the ECST and NASCET trials in symptomatic patients followed by ACAS and ACST in asymptomatic patients.2-5 However, this proved to be only a temporary respite because by the late 1990s, CEA was once again the subject of scrutiny following the emergence of carotid artery stenting (CAS) as a viable and less invasive alternative.6 However, despite initial optimism following Browns 1992 systematic review (30-day death/stroke rate after unprotected angioplasty without stenting was <1% in 123 pooled patients6), no fewer than 12 RCTs8 have subsequently failed to resolve the debate. The 2007 Cochrane Review concluded that CAS conferred significant reductions in cranial nerve injury (a very important observation), but that it was associated with a significant increase in the 30-day risk of death/any stroke and any stroke. There was no difference regarding 30-day death and death/disabling stroke, nor the risk of late stroke.7
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
